+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Tapentadol Market by Application (Cough Treatment, Pain Management), End User (Clinic, Hospital, Pharmacy) - Forecast 2024-2030- Product Image
Global Tapentadol Market by Application (Cough Treatment, Pain Management), End User (Clinic, Hospital, Pharmacy) - Forecast 2024-2030- Product Image
Sale

Global Tapentadol Market by Application (Cough Treatment, Pain Management), End User (Clinic, Hospital, Pharmacy) - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896819
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Tapentadol Market size was estimated at USD 3.86 billion in 2023, USD 4.10 billion in 2024, and is expected to grow at a CAGR of 6.38% to reach USD 5.95 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tapentadol Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tapentadol Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tapentadol Market, highlighting leading vendors and their innovative profiles. These include Apotex Corporation, Arene Life Sciences limited, Cadila Pharmaceuticals Ltd., Curia Global, Inc., Grünenthal GmbH, IPCA Laboratories Ltd., Johnson & Johnson Services, Inc., Lupin Laboratories Ltd., Manus Aktteva Biopharma LLP, Physicians Total Care, Inc., Quality Care Products, Sun Pharmaceutical Industries Limited, Taj Pharmaceutical Limited, Tirupati Medicare Ltd, and Virupaksha Group.

Market Segmentation & Coverage

This research report categorizes the Tapentadol Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Application
    • Cough Treatment
    • Pain Management
      • Cancer Pain
      • Neuropathic Pain
  • End User
    • Clinic
    • Hospital
    • Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Tapentadol Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tapentadol Market?
  3. What are the technology trends and regulatory frameworks in the Tapentadol Market?
  4. What is the market share of the leading vendors in the Tapentadol Market?
  5. Which modes and strategic moves are suitable for entering the Tapentadol Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Tapentadol Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High occurrence of chronic musculoskeletal pain
5.1.1.2. Rising demand for over-the-counter painkillers
5.1.1.3. Escalating prevalence of diabetes and increasing need for analgesics
5.1.2. Restraints
5.1.2.1. Side effects associated with tapentadol
5.1.3. Opportunities
5.1.3.1. Advancement in treatment and therapeutics development
5.1.3.2. Exponential availability through online pharmacies
5.1.4. Challenges
5.1.4.1. Strict government regulations and availability of substitute
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Tapentadol Market, by Application
6.1. Introduction
6.2. Cough Treatment
6.3. Pain Management
6.4.1. Cancer Pain
6.4.2. Neuropathic Pain
7. Tapentadol Market, by End User
7.1. Introduction
7.2. Clinic
7.3. Hospital
7.4. Pharmacy
8. Americas Tapentadol Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Tapentadol Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Tapentadol Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Apotex Corporation
12.1.2. Arene Life Sciences limited
12.1.3. Cadila Pharmaceuticals Ltd.
12.1.4. Curia Global, Inc.
12.1.5. Grünenthal GmbH
12.1.6. IPCA Laboratories Ltd.
12.1.7. Johnson & Johnson Services, Inc.
12.1.8. Lupin Laboratories Ltd.
12.1.9. Manus Aktteva Biopharma LLP
12.1.10. Physicians Total Care, Inc.
12.1.11. Quality Care Products
12.1.12. Sun Pharmaceutical Industries Limited
12.1.13. Taj Pharmaceutical Limited
12.1.14. Tirupati Medicare Ltd
12.1.15. Virupaksha Group
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. TAPENTADOL MARKET RESEARCH PROCESS
FIGURE 2. TAPENTADOL MARKET SIZE, 2022 VS 2030
FIGURE 3. TAPENTADOL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TAPENTADOL MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. TAPENTADOL MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. TAPENTADOL MARKET DYNAMICS
FIGURE 7. TAPENTADOL MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 8. TAPENTADOL MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. TAPENTADOL MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 10. TAPENTADOL MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. TAPENTADOL MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. TAPENTADOL MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. TAPENTADOL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. TAPENTADOL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TAPENTADOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 6. TAPENTADOL MARKET SIZE, BY COUGH TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 9. TAPENTADOL MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TAPENTADOL MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. TAPENTADOL MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TAPENTADOL MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TAPENTADOL MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. CANADA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CANADA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 27. CANADA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. MEXICO TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. MEXICO TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 30. MEXICO TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. CHINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CHINA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 44. CHINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. INDIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. INDIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 47. INDIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. JAPAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. JAPAN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 53. JAPAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. THAILAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. THAILAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 71. THAILAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. DENMARK TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. DENMARK TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 81. DENMARK TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EGYPT TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EGYPT TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 84. EGYPT TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. FINLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. FINLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 87. FINLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. FRANCE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FRANCE TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 90. FRANCE TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. GERMANY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. GERMANY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 93. GERMANY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ITALY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 99. ITALY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. NORWAY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NORWAY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 108. NORWAY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. POLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. POLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 111. POLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. QATAR TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. QATAR TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 114. QATAR TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SPAIN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 126. SPAIN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. TURKEY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TURKEY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 135. TURKEY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. TAPENTADOL MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 143. TAPENTADOL MARKET SHARE, BY KEY PLAYER, 2022
TABLE 144. TAPENTADOL MARKET LICENSE & PRICING

Companies Mentioned

  • Apotex Corporation
  • Arene Life Sciences limited
  • Cadila Pharmaceuticals Ltd.
  • Curia Global, Inc.
  • Grünenthal GmbH
  • IPCA Laboratories Ltd.
  • Johnson & Johnson Services, Inc.
  • Lupin Laboratories Ltd.
  • Manus Aktteva Biopharma LLP
  • Physicians Total Care, Inc.
  • Quality Care Products
  • Sun Pharmaceutical Industries Limited
  • Taj Pharmaceutical Limited
  • Tirupati Medicare Ltd
  • Virupaksha Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.95 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Tapentadol Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Image

Global Tapentadol Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • 194 Pages
  • Global
From
Tapentadol Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Tapentadol Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 84 Pages
  • Global
From
Tapentadol (CAS 175591-23-8) Global Market Research Report 2024 - Product Image

Tapentadol (CAS 175591-23-8) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Pain Management Devices Market by Product (Analgesic Infusion Pumps, Electrical Stimulators, Neurostimulation), Application (Cancer, Facial & migraine, Musculoskeletal disorder), End-user - Forecast 2024-2030 - Product Image

Global Pain Management Devices Market by Product (Analgesic Infusion Pumps, Electrical Stimulators, Neurostimulation), Application (Cancer, Facial & migraine, Musculoskeletal disorder), End-user - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Global Cancer Pain Management Market by Drug Type (Nerve Blockers, Non-Opioids, Opioids), Route of Administration (Oral, Parental), Application, End-Use - Forecast 2024-2030 - Product Image

Global Cancer Pain Management Market by Drug Type (Nerve Blockers, Non-Opioids, Opioids), Route of Administration (Oral, Parental), Application, End-Use - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From

About the Tapentadol Market

Tapentadol is an opioid analgesic used to treat moderate to severe pain. It is a centrally acting synthetic analgesic with a dual mechanism of action, acting on both the mu-opioid receptor and the norepinephrine reuptake inhibitor. Tapentadol is available in both immediate-release and extended-release formulations. It is used to treat a variety of conditions, including chronic pain, neuropathic pain, and post-operative pain. Tapentadol is generally well-tolerated and has fewer side effects than other opioids. Tapentadol is a relatively new analgesic on the market, but it has been gaining popularity due to its efficacy and safety profile. It is increasingly being used as an alternative to other opioids, such as oxycodone and hydrocodone. Tapentadol is also being used in combination with other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs), to provide more effective pain relief. Some of the companies in the Tapentadol market include Grünenthal, Endo Pharmaceuticals, and Purdue Pharma. Grünenthal is the manufacturer of the brand name Tapentadol, while Endo Pharmaceuticals and Purdue Pharma both produce generic versions of the drug. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.